Who are Prexton Therapeutics's investors?

Prexton Therapeutics's investors include Cardinal Partners, M Ventures, Seroba Life Sciences, Sunstone Capital, Ysios Capital, Forbion.

Who acquired Prexton Therapeutics?

Prexton Therapeutics was acquired by Lundbeck.

Where is Prexton Therapeutics headquartered?

Prexton Therapeutics is headquartered in Copenhagen, DK.

Prexton Therapeutics

acquired by Lundbeck

Copenhagen, DK · Founded 1915 · 6,027 employees on LinkedIn · 6 known investors

Find your way into Prexton Therapeutics

Paths you didn't know you had: your email and LinkedIn already hold routes to the Prexton Therapeutics team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Prexton Therapeutics was a biopharmaceutical company developing novel therapies for Parkinson's disease, including its lead mGluR4 modulator candidate foliglurax. Acquired by Lundbeck in 2018.

Biotech Healthtech Medical Devices

Investors · 6

Cardinal Partnerslisted by Cardinal PartnersPrinceton

How we know: Cardinal Partners's portfolio page · Not right? Tell us

M Ventureslisted by M VenturesAmsterdam · $10.8M

How we know: M Ventures's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

Seroba Life Scienceslisted by Seroba Life SciencesDublin · $540K – $7.6M

How we know: Seroba Life Sciences's portfolio page · a partner's Signal profile · Not right? Tell us

Sunstone Capitallisted by Sunstone CapitalFrederiksberg

How we know: Sunstone Capital's portfolio page · funding news · the VCSheet dataset · Not right? Tell us

Ysios Capitallisted by Ysios CapitalBarcelona · $5.4M – $21.6M

How we know: Ysios Capital's portfolio page · funding news · the VCSheet dataset · Not right? Tell us

ForbionreportedNaarden

How we know: a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us

Related companies · 1

Naver financeNaver Financial is the fintech arm of South Korean internet group Naver Corp., set to absorb Upbit operator Dunamu.

Companies working in the same space as Prexton Therapeutics.

Frequently asked questions

What does Prexton Therapeutics do?: Prexton Therapeutics was a biopharmaceutical company developing novel therapies for Parkinson's disease, including its lead mGluR4 modulator candidate foliglurax. Acquired by Lundbeck in 2018.
Who are Prexton Therapeutics's investors?: Prexton Therapeutics's investors include Cardinal Partners, M Ventures, Seroba Life Sciences, Sunstone Capital, Ysios Capital, Forbion.
Who acquired Prexton Therapeutics?: Prexton Therapeutics was acquired by Lundbeck.
Where is Prexton Therapeutics headquartered?: Prexton Therapeutics is headquartered in Copenhagen, DK.